GLYCOPYRROLATE​

​

Glycopyrrolate is an important drug in anesthesia due to its anticholinergic properties. It acts by blocking the action of acetylcholine on muscarinic receptors, thus inhibiting the parasympathetic nervous system. Glycopyrrolate has several applications in anesthesia, which contribute to its importance:

​

1. Counteracting muscarinic side effects of cholinesterase inhibitors: Cholinesterase inhibitors such as neostigmine are used to reverse non-depolarizing neuromuscular blockade. However, increasing acetylcholine levels can lead to unwanted muscarinic side effects such as bradycardia, bronchoconstriction, and increased secretions. Glycopyrrolate is often co-administered with neostigmine to prevent these side effects, allowing for safe and effective reversal of neuromuscular blockade.

2. Reduction of airway secretions: Glycopyrrolate can reduce airway secretions, which is particularly beneficial in certain procedures, such as bronchoscopy or laryngoscopy. 

3. Management of bradycardia: Glycopyrrolate can be used to treat bradycardia during anesthesia or surgery. It can also be administered prophylactically in situations where there is a high risk of bradycardia, such as during ophthalmic or neurosurgical procedures.

4. Antisialagogue effect: Glycopyrrolate's antisialagogue effect (reduction of saliva production) can be useful in certain surgical procedures where excessive saliva may interfere with the surgical field or pose an aspiration risk.

5. Prevention of vagal reflexes: Some surgical manipulations can trigger vagal reflexes, leading to bradycardia, hypotension, or even cardiac arrest. Glycopyrrolate can help prevent these reflexes by blocking the action of acetylcholine on muscarinic receptors.

​​

​

Here are the main steps in glycopyrrolate's mechanism of action:

​

1. Binding to muscarinic receptors: Glycopyrrolate competitively binds to muscarinic acetylcholine receptors, which are G-protein-coupled receptors found throughout the body, particularly in the smooth muscles, glands, and the central and peripheral nervous systems.

2. Antagonism of muscarinic receptors: By binding to muscarinic receptors, glycopyrrolate prevents the interaction between acetylcholine and the receptors. This results in the inhibition of the downstream effects that are normally triggered by the activation of muscarinic receptors, such as decreased cyclic AMP production, increased intracellular calcium levels, and activation of various ion channels.

3. Antisecretory and antispasmodic effects: Glycopyrrolate's antagonism of muscarinic receptors in the gastrointestinal tract reduces the secretion of gastric acid and other gastrointestinal secretions, as well as relaxes the smooth muscle of the gastrointestinal tract. This leads to reduced motility and spasm, making glycopyrrolate useful for treating peptic ulcers and other gastrointestinal disorders.

4. Bronchodilation: In the respiratory system, glycopyrrolate's muscarinic receptor antagonism causes bronchodilation by relaxing the smooth muscles in the bronchi, which can improve airflow and reduce airway resistance in patients with COPD or asthma.

5. Reduction of secretions and vagal reflexes during anesthesia: Glycopyrrolate is often used during anesthesia to decrease airway secretions and block vagal reflexes, which can cause bradycardia or hypotension. By inhibiting muscarinic receptors in the heart and airways, glycopyrrolate helps to maintain stable heart rate and blood pressure during surgical procedures.

​

​

                                                                                         Key points about Glycopyrrolate

 

• Glycopyrrolate is indicated for use as a preoperative antimuscarinic to reduce salivary, tracheobronchial, and pharyngeal secretions, to reduce the volume and free acidity of gastric secretions, and, to block cardiac vagal inhibitory reflexes during induction of anesthesia and intubation.

 

• Quaternary amine and muscarinic receptor antagonist.

 

• It does not cross the blood brain barrier nor the placenta.

 

• Very potent antisialogue (drying agent).

 

• It will increase heart rate but less than Atropine.

 

• Frequently used in conjunction with Neostigmine.

 

• Can be given with Ketamine to minimize salivation.

 

​​

​​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

 

​​

​​